Safety and Immunogenicity of the BBIBP-CorV Vaccine in Adolescents Aged 12 to 17 Years in the Thai Population: An Immunobridging Study.
Tawinprai K, Siripongboonsitti T, Porntharukchareon T, Vanichsetakul P, Thonginnetra S, Niemsorn K, Promsena P, Tandhansakul M, Kasemlawan N, Ruangkijpaisal N, Banomyong N, Phattraprayoon N, Ungtrakul T, Wittayasak K, Thonwirak N, Soonklang K, Sornsamdang G, Mahanonda N.
Tawinprai K, et al. Among authors: siripongboonsitti t.
Vaccines (Basel). 2022 May 19;10(5):807. doi: 10.3390/vaccines10050807.
Vaccines (Basel). 2022.
PMID: 35632562
Free PMC article.